RICHMOND, Va. (AP) — GlaxoSmithKline will pay Virginia more than $2 million as part of a settlement between the drug maker and 45 states.
Attorney General Mark R. Herring says the $105 million settlement resolves allegations that GlaxoSmithKline improperly marketed the asthma drug Advair and two antidepressant drugs.
Herring said Wednesday in a news release that Virginia will use its share of the settlement to support future consumer protection enforcement activities.
The settlement requires the company to continue a program through March 2019 that reduces financial incentives for sales representatives to engage in deceptive marketing. The company also must change its marketing practices.
Herring says the settlement is awaiting the approval of Richmond Circuit Court.